Navigation Links
Lighting up can bring you down in colorectal surgery
Date:9/24/2013

Infection, pneumonia, blood clots and kidney failure are all possible complications after any major surgery. A new study shows that smoking boosts the risk of such complications following some of the most common colorectal procedures, including surgery for colon cancer, diverticulitis or inflammatory bowel disease. Lighting up also increases a patient's risk of death after surgery compared with patients who have never smoked.

The study, published in the Annals of Surgery, is unique because it focuses on elective, or non-emergency, surgeries.

"Elective surgeries are planned, so there's a built-in window of opportunity for patients to stop smoking beforehand," said Fergal J. Fleming, M.D., lead study author and assistant professor in the Department of Surgery at the University of Rochester Medical Center. "We know that stopping smoking even as little as six weeks before a procedure can reduce the risk of complications."

Past research has shown that a diagnosis of cancer or the scheduling of major surgery is a time when patients may be more motivated to quit smoking. Fleming says physicians need to take full advantage of these "teachable moments" and strongly encourage patients to enter a smoking cessation program, as it could go a long way in fending off post-surgical complications.

According to the Centers for Disease Control and Prevention, one in five American adults smoke, and millions of these patients undergo surgery every year. Physicians have long known that smoking is a risk factor for increased surgical complications, but this is the first large study to focus specifically on the effects of smoking after colorectal surgery.

Fleming's team tapped a large database from the American College of Surgeon's to identify patients undergoing major, non-emergency colorectal surgery. More than 47,000 patients were identified; approximately 26,000 had surgery for colorectal cancer, 14,000 for diverticular disease (small, inflamed "pockets" forming along the colon wall) and 7,000 for inflammatory bowel disease. Twenty percent of patients were current smokers, 19 percent were ex-smokers and the rest had never smoked.

After accounting for patient age, body mass index, alcohol use and other health conditions, the team's analysis showed that current smokers still had an estimated 30 percent increased risk of dying or developing complications following colorectal surgery compared with never-smokers. Current smokers, who were younger than never-smokers and ex-smokers, had the highest rates of pneumonia and infection, were more likely to return to the operating room and had much longer hospital stays after surgery.

Researchers also observed that patients with long histories of smoking were at even greater risk: All complications and the risk of death were significantly higher in patients who had smoked two packs a day for more than 30 years.

Building on this research, Fleming plans to study how doctors can better partner with patients to encourage them to quit smoking before planned surgeries.

"Anecdotally, we know that many patients don't take the opportunity to quit or join a smoking cessation program before surgery," he said. "We want to find out what motivates patients, how can we make them a major player in their own care, and how can we as physicians do a better job of explaining issues like this to patients."


'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Glazing Contractors Gain Opportunities in High-Performance Translucent Daylighting with New ProStock Program by Duo-Gard
2. Rotarians Are Lighting the World
3. Noribachi Showcases Superior Capability of LED Lighting Systems with Prototype Lamp
4. CSL® (Creative Systems Lighting) Debuts Redesigned Website for LED and Other Architectural Lighting Products
5. 911 Signal USA Release Updated 2013 Emergency Vehicle Lighting Color Guide by State
6. Outlook with Ben Kingsley Spotlighting Glaucoma in Upcoming Report
7. 3W High Power LED Down Light [ZT-D70-311F] Is Introduced to Customers by Zhongtian Lighting
8. BDry.com Highlighting Importance of Foundation Integrity and Extending its Repair Services to Fix Cracked Walls
9. Orriant Releases Corporate Wellness Case Study Results Highlighting the Success of a Police Sergeant and His Family
10. CSL® (Creative Systems Lighting) Wins Two 2013 Green GOOD DESIGN™ Awards
11. 60W High Lumen LED Flood Light from Zhongtian Lighting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: